Therapeutic Goods Administration of Australia authorized Moderna’s Covid-19 vaccine in children (6-11 Years)
On Feb. 16, 2022, Moderna announced that the Therapeutic Goods Administration in Australia had granted provisional registration for…
On Feb. 16, 2022, Moderna announced that the Therapeutic Goods Administration in Australia had granted provisional registration for…
On Jan. 19, 2022, Novavaxa announced that Australia’s Therapeutic Goods Administration had granted approval for provisional registration of…
On Dec. 13, 2021, Moderna announced an agreement with the Australian Government to build a state-of-the-art messenger RNA…
On Oct. 29, 2021, Novavax announced the completion of its rolling submission to the Therapeutic Goods Administration (TGA)…
On Aug. 18, 2021, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
On Aug. 9, 2021, Moderna announced that the Therapeutic Goods Administration (TGA) had granted provisional registration to the…
On May 12, 2021, Moderna announced a new supply agreement with the government of Australia for 25 million…
On Jan, 18, 2021, researchers in Konstanz, Wurzburg, Hamburg and Vienna, led by evolutionary biologist Professor Axel Meyer…
On Jan. 7, 2021, Novavax announced that it had executed an Advance Purchase Agreement with the Commonwealth of…
On Nov. 4, 2020, Novavax announced the signing of a non-binding Heads of Terms document with the Australian…
On Oct. 6, 2020, the U.S. Department of Health and Human Services announced funding of a patch that…
On Sept. 14, 2020, Illumina announced that the Australian public health laboratories will aim to sequence the virus…
On Sept. 3, 2020, BioMedomics announced that the Therapeutic Goods Administration, a branch of the Department of Health…
On Sept. 2, 2020, Mesoblast announced that it had received ethics approval to include Australian hospitals in the…
On Aug. 3, 2020, Atossa Therapeutics announced that it had received approval from the ethics committee to open…
On Jul. 16, 2020, Atossa Therapeutics announced that it has contracted with Avance Clinical to conduct a clinical…
On Jul. 13, 2020, an emerging virus threatens both wild and pet rabbits in the U.S. The fatal…
On Jun. 10, 2020, the World Trade Organizationメs (WTO) Appellate Body reported on the dispute brought by Honduras…
On Apr. 29, 2020, an anti-inflammatory drug developed at Scripps Research 25 years ago tested as a way…
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
On Apr. 9, 2020, James Petrie, a graduate student in applied mathematics at the University of Waterloo in…
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
On May 24, 2018, the United States Food and Drug Administration (U.S. FDA) released a statement on GR2E…
On Sept. 10, 2014, an international team of scientists from Singapore, Thailand, China and Australia announced that they…
On Jun. 28, 2011, to prevent extinction of the Tasmanian tiger, a team of scientists led by the…
On Jun. 15, 2008, Australia announced it had approved the first locally made vaccine to protect humans from…
On Sept. 28, 2007, the U.S. Food and Drug Administration (FDA) approved an Australian-made influenza vaccine called Afluria…
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
In 2006, the Malaria Atlas Project (MAP) was founded as an international research collaboration that tracks the global…
In 1996, the first official case of devil tumor facial disease was reported. Devil Facial Tumour Disease (DFTD)…